Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis

PURPOSE: To compare the efficacy and safety of transarterial chemoembolization (TACE) plus sorafenib and immune checkpoint inhibitors (T+S+ICIs) and TACE plus sorafenib (T+S) when treating patients with advanced hepatocellular carcinoma (HCC) who have previously received locoregional treatment. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue-Gang, Sun, Yan-Yuan, Wang, Hai-Qing, Li, De-Shan, Xu, Guo-Hui, Huang, Xiao-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513034/
https://www.ncbi.nlm.nih.gov/pubmed/36176392
http://dx.doi.org/10.3389/fonc.2022.914385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513034/
https://www.ncbi.nlm.nih.gov/pubmed/36176392
http://dx.doi.org/10.3389/fonc.2022.914385

Ejemplares similares